EV/EBITDA
-0.38
+0.02+5.00%
19 min ago
Summary
- As of February 7, 2025, ALXO EV/EBITDA is -0.38, with a rise of +0.02 (+5.00%) during the most recent trading day.
- Over the past year, ALXO EV/EBITDA has increased by +4.43 (+92.10%).
- ALXO EV/EBITDA is now -5.56% below its all-time high of -0.36.
Performance
ALXO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ALXO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.0% | -5.3% | -4.8% |
| 1 m1 month | +39.7% | -39.9% | -37.4% |
| 3 m3 months | +25.5% | -25.7% | -23.7% |
| 6 m6 months | +50.0% | -56.2% | -53.5% |
| ytdytd | +32.1% | -32.3% | -30.0% |
| 1 y1 year | +92.1% | -92.6% | -92.3% |
| 5 y5 years | - | - | - |
ALXO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.6% | -0.63 | +39.7% | |
| 3 m | 3-month | -0.36 | -5.6% | -0.63 | +39.7% |
| 6 m | 6-month | -0.36 | -5.6% | -0.80 | +52.5% |
| 1 y | 1-year | -0.36 | -5.6% | -5.56 | +93.2% |
| 3 y | 3-year | -0.36 | -5.6% | -6.75 | +94.4% |
| 5 y | 5-year | -0.36 | -5.6% | -116.18 | +99.7% |
| alltime | all time | -0.36 | -5.6% | -116.18 | +99.7% |
ALX Oncology Holdings EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.38(-32.1%) |
| 2024 | -0.56(-88.2%) |
| 2023 | -4.76(+42.1%) |
| Date | Value |
|---|---|
| 2022 | -3.35(-45.1%) |
| 2021 | -6.10(-91.2%) |
| 2020 | -69.04 |
FAQ
- What is ALX Oncology Holdings EV/EBITDA?
- What is the all time high EV/EBITDA for ALX Oncology Holdings?
- What is ALXO EV/EBITDA year-to-date change?
- What is ALX Oncology Holdings EV/EBITDA year-on-year change?
What is ALX Oncology Holdings EV/EBITDA?
The current EV/EBITDA of ALXO is -0.38
What is the all time high EV/EBITDA for ALX Oncology Holdings?
ALX Oncology Holdings all-time high EV/EBITDA is -0.36
What is ALXO EV/EBITDA year-to-date change?
ALX Oncology Holdings EV/EBITDA has changed by +0.18 (+32.14%) since the beginning of the year
What is ALX Oncology Holdings EV/EBITDA year-on-year change?
Over the past year, ALXO EV/EBITDA has changed by +4.43 (+92.10%)